Article
The use of dominant-negative mutations to elucidate signal transduction pathways in lymphocytes.
Current opinion in immunology - 1 Apr 1996
Perlmutter R M, Alberola-Ila J
Abstract excerpt
Recent publications document an exponential increase in the use of dominant-negative mutations as tools for the experimental dissection of lymphocyte signaling pathways. This approach may be the only one available for in vitro analysis of cell lines. Moreover, when implemented in transgenic animals, dominant-negative mutations boast certain advantages over gene-targeting strategies.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.